UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
Amendment No. 1
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: August 11, 2022
Commission File Number:
(Translation of registrant's name into English)
6 rue Alain Bombard
44800 Saint-Herblain, France
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
EXPLANATORY NOTE
Except as described above, this Amendment speaks as of the original filing date of the Original 6-K and does not amend, update or restate any information set forth in the Original 6-K or reflect any events that occurred subsequent to the original filing date of the Original 6-K.
| Exhibit | ||
| 99.1 | Unaudited Consolidated Interim Financial Statements at March 31, 2022 | |
| 101.SCH | XBRL Taxonomy Extension Schema Document | |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document | |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Valneva SE | ||
| (Registrant) | ||
| Date: August 11, 2022 | /s/ Thomas Lingelbach | |
| Thomas Lingelbach | ||
| Chief Executive Officer and President | ||
Exhibit 99.1
 |
VALNEVA SE - CONSOLIDATED FINANCIAL STATEMENTS 2022 |
1 |
CONSOLIDATED FINANCIAL STATEMENTS 2022
VALNEVA
A European Company (Societas Europaea) with a Management and a Supervisory Board
Registered offices:
6 rue Alain Bombard, 44800 SAINT-HERBLAIN - France
Nantes Companies Register (RCS) No. 422 497 560
Unaudited Consolidated Interim financial
statements
as at March 31, 2022
| VALNEVA SE - CONSOLIDATED FINANCIAL STATEMENTS 2022 | 2 |
| 1. | Unaudited interim consolidated statements of income (loss) and comprehensive income (Loss) |
| 1.1 | Unaudited Interim Condensed Consolidated Statements of Income (Loss) |
| € in thousand | Three months ended March 31, | |||||||
| (except per share amounts) | 2022 | 2021 | ||||||
| Product sales | ||||||||
| Other revenues | ||||||||
| Revenues | ||||||||
| Cost of goods and services | ( | ) | ( | ) | ||||
| Research and development expenses | ( | ) | ( | ) | ||||
| Marketing and distribution expenses | ( | ) | ( | ) | ||||
| General and administrative expenses | ( | ) | ( | ) | ||||
| Other income and expenses, net | ||||||||
| OPERATING LOSS | ( | ) | ( | ) | ||||
| Finance income | ||||||||
| Finance expenses | ( | ) | ( | ) | ||||
| Result from investments in associates | ( | ) | ||||||
| LOSS BEFORE INCOME TAX | ( | ) | ( | ) | ||||
| Income tax income/(expense) | ( | ) | ||||||
| LOSS FOR THE PERIOD | ( | ) | ( | ) | ||||
Losses per share for profit/loss for the period attributable to the equity holders of the Company, expressed in € per share | ||||||||
| - basic | ( | ) | ( | ) | ||||
| - diluted | ( | ) | ( | ) | ||||
| VALNEVA SE - CONSOLIDATED FINANCIAL STATEMENTS 2022 | 3 |
| 1.2 | Unaudited Interim Condensed Consolidated Statement of Comprehensive Income (Loss) |
| € in thousand | Three months ended March 31, | |||||||
| 2022 | 2021 | |||||||
| Loss for the period | ( | ) | ( | ) | ||||
| Other comprehensive income/(loss) | ||||||||
| Items that may be reclassified to profit or loss | ||||||||
| Currency translation differences | ( | ) | ( | ) | ||||
| Items that will not be reclassified to profit or loss | ||||||||
| Defined benefit plan actuarial gains/(losses) | ||||||||
Other comprehensive loss for the period, net of tax | ( | ) | ( | ) | ||||
TOTAL COMPREHENSIVE LOSS FOR THE PERIOD ATTRIBUTABLE TO THE OWNERS OF THE COMPANY | ( | ) | ( | ) | ||||
| 2 | Unaudited Interim Condensed Consolidated balance sheets |
| € in thousand | March 31, | December 31, | ||||||
| 2022 | 2021 | |||||||
| ASSETS | ||||||||
| Non-current assets | ||||||||
| Intangible assets | ||||||||
| Right of use assets | ||||||||
| Property, plant and equipment | ||||||||
| Investments in associates | ||||||||
| Deferred tax assets | ||||||||
| Other non-current assets | ||||||||
| Current assets | ||||||||
| Inventories | ||||||||
| Trade receivables | ||||||||
| Other current assets | ||||||||
| Cash and cash equivalents | ||||||||
| Total assets | ||||||||
| EQUITY | ||||||||
| Capital and reserves attributable to the Company’s equity holders | ||||||||
| Share capital | ||||||||
| Share premium | ||||||||
| Other reserves | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Loss for the period | ( | ) | ( | ) | ||||
| LIABILITIES | ||||||||
| Non-current liabilities | ||||||||
| Borrowings | ||||||||
| Lease liabilities | ||||||||
| Contract liabilities | ||||||||
| Refund liabilities | ||||||||
| Provisions | ||||||||
| Deferred tax liabilities | ||||||||
| Other liabilities | ||||||||
| Current liabilities | ||||||||
| Borrowings | ||||||||
| Trade payables and accruals | ||||||||
| Income tax liability | ||||||||
| Tax and Employee-related liabilities | ||||||||
| Lease liabilities | ||||||||
| Contract liabilities | ||||||||
| Refund liabilities | ||||||||
| Provisions | ||||||||
| Other liabilities | ||||||||
| Total liabilities | ||||||||
| Total equity and liabilities |
| VALNEVA SE - CONSOLIDATED FINANCIAL STATEMENTS 2022 | 4 |
| 3 | Unaudited Interim Condensed Consolidated statements of cash flows |
| € in thousand | Three months ended March 31, | |||||||
| 2022 | 2021 | |||||||
| Cash flows from operating activities | ||||||||
| Loss for the period | ( | ) | ( | ) | ||||
| Adjustments for non-cash transactions | ( | ) | ||||||
| Changes in non-current operating assets and liabilities | ( | ) | ||||||
| Changes in working capital | ||||||||
| Cash generated from/(used in) operations | ( | ) | ||||||
| Income tax paid | ( | ) | ( | ) | ||||
| Net cash generated from/(used in) operating activities | ( | ) | ||||||
| Cash flows from investing activities | ||||||||
| Purchases of property, plant and equipment | ( | ) | ( | ) | ||||
| Purchases of intangible assets | ( | ) | ( | ) | ||||
| Interest received | ||||||||
| Net cash used in investing activities | ( | ) | ( | ) | ||||
| Cash flows from financing activities | ||||||||
| Proceeds from issuance of common stock, net of costs of equity transactions | ||||||||
| Disposal of treasury shares | ||||||||
| Payment of lease liabilities | ( | ) | ( | ) | ||||
| Interest paid | ( | ) | ( | ) | ||||
| Net cash generated from/(used in) financing activities | ( | ) | ||||||
| Net change in cash and cash equivalents | ( | ) | ||||||
| Cash and cash equivalents at beginning of the period | ||||||||
| Exchange gains/(losses) on cash | ( | ) | ||||||
| Restricted cash | ||||||||
| Cash and cash equivalents at end of the period | ||||||||
| VALNEVA SE - CONSOLIDATED FINANCIAL STATEMENTS 2022 | 5 |
| 4 | Unaudited Interim Condensed Consolidated statements of changes in equity |
€ in thousand (except number of shares) | Number of shares issued | Share capital | Share premium | Other reserves | Retained earnings/ (Accumulated deficit) | Profit/ (loss) for the period | Total equity | |||||||||||||||||||||
Balance as at January 1, 2021 | ( | ) | ( | ) | ||||||||||||||||||||||||
| Total comprehensive loss | — | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||
| Income appropriation | — | ( | ) | |||||||||||||||||||||||||
| Share-based compensation expense: | ||||||||||||||||||||||||||||
| - value of services | — | |||||||||||||||||||||||||||
| - exercises | ||||||||||||||||||||||||||||
| Treasury shares | — | |||||||||||||||||||||||||||
Balance as at March 31, 2021 | ( | ) | ( | ) | ||||||||||||||||||||||||
Balance as at January 1, 2022 | ( | ) | ( | ) | ||||||||||||||||||||||||
| Total comprehensive loss | — | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||
| Income appropriation | — | ( | ) | |||||||||||||||||||||||||
| Share-based compensation expense: | ||||||||||||||||||||||||||||
| - value of services | — | |||||||||||||||||||||||||||
| - exercises | ||||||||||||||||||||||||||||
| Treasury shares | — | |||||||||||||||||||||||||||
Balance as at March 31, 2022 | ( | ) | ( | ) | ||||||||||||||||||||||||